Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic Lysergic Acid Diethylamide (LSD) derivative. BETR-001 mimics the projected therapeutic properties of LSD without causing its undesirable side effects such as hallucinations and cardiac toxicity. BETR-001 is a therapy to treat debilitating psychiatric disorders with high unmet need, such as major depressive disorder and anxiety disorders; as well as neurological disorders such as neuropathic pain. BETR-002 is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound for treatment of benzodiazepine dependency, anxiety and spasticity. The Company also owns a drug candidate for the treatment of viral infections such as COVID-19. The Company’s subsidiaries include MedMelior Inc., BetterLife Pharma US Inc. and Blife Therapeutics Inc.


CSE:BETR - Post by User

Comment by MichaelJRNon Sep 22, 2020 11:49am
124 Views
Post# 31597466

RE:RE:RE:Pump and dump scam here.

RE:RE:RE:Pump and dump scam here.

Let me get this right... The team is comprised of huge scam artists whose goal was to merge two companies, pick up stock, and then unload it all a few hundred shares at a time racing to the bottom before the investors can. This makes zero sense. I'd believe it if a bunch of fake news was being released post merger to drive the stock price up giving them the opportunity to unload. The terrible daily volume contradicts your claims. 

They have slated clinical trials for October as well as engaging List Labs to produce Interferon for them. Regardless of mismanagement postponing clinical trials pre merger which has got us to this position today. Any positive outcome of the October trials should put them on the map so to speak. 

Again... trading on the OTC has still not commenced. No marketing firm is going to start a campaign without a full audience. 

I'm not a cheerleader although I would like my investment to pay off. Huge potential here so long as they are funded and able to stay on schedule. 

<< Previous
Bullboard Posts
Next >>